📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Application of Antisense Conjugates for the Treatment of Myotonic Dystrophy Type 1. (2023)

First Author: Stoodley J
Attributed to:  Advanced peptide-oligonucleotide therapy for Myotonic Dystrophy Type 1 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/ijms24032697

PubMed Identifier: 36769018

Publication URI: http://europepmc.org/abstract/MED/36769018

Type: Journal Article/Review

Volume: 24

Parent Publication: International journal of molecular sciences

Issue: 3

ISSN: 1422-0067